DNA Sequencing from PCR Products

This chapter provides a procedure and some advice for direct sequencing of PCR products from DNA extracted from formalin fixed and paraffin embedded (FFPE) tissues. A section in detail is dedicated to the analysis of the electropherograms. Generally, mutational analysis requires the extraction of DNA from FFPE, PCR amplification and PCR product purification and sequencing. The chapter is dedicated particularly to the analysis of somatic mutations in tumour tissues specifying the importance of analyzing a limited amount of non-mutated DNA component in order to obtain good quality and analyzable electropherograms.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic €32.70 /Month

Buy Now

Price includes VAT (France)

eBook EUR 96.29 Price includes VAT (France)

Softcover Book EUR 126.59 Price includes VAT (France)

Tax calculation will be finalised at checkout

Purchases are for personal use only

Similar content being viewed by others

COLD-PCR: Applications and Advantages

Chapter © 2016

A robust targeted sequencing approach for low input and variable quality DNA from clinical samples

Article Open access 15 January 2018

PCR Techniques in Next-Generation Sequencing

Chapter © 2016

Notes

Artifacts are ex novo sequence alterations introduced by the Taq polymerase during the PCR reaction that become visible in the electropherogram when the enzyme amplifies a single strand of damaged DNA. This situation appears when few nanograms of DNA template are used (i.e. 10 ng or less) or when DNA template has high degradation levels (such as DNA from formalin-fixed samples). The expected frequency of artifacts can be considered around 1/4,000 in fresh frozen samples and 1/1,000 bp in formalin fixed samples

There are commercial PCR premixed solutions for convenient PCR setup, containing PCR buffer and dNTPs. Usually Taq Polymerase is provided with its dedicated 10x buffer. Check the composition for the presence of MgCl2. Different commercial PCR buffers are MgCl2 free but a 25 mM or 50 mM MgCl2 solution is supplied with buffer and enzyme. MgCl2 content could be incremented in cases of multiplex PCR or decremented in cases of high fidelity PCR

Primer design could be performed using specific software, please refer to http://molbiol-tools.ca/PCR.htm for the on line available software. Since the first 20–40 bases of the electropherograms are not usually reliable, it is necessary to design primers that match about 40–50 bases before the region of interest

Primer design depends on the quality of starting material. For sub-optimal quality of material (for example DNA from FFPE), shorter PCR products are recommended. However, using higher amounts of starting DNA, the probability to have some intact template molecule is higher and products up to 400 bp can be obtained from FFPE or even longer from alcoholic fixatives. When working with highly damaged DNA, we suggest designing primers for amplicons of around 150 base pairs even if it would cover a short region of interest

In the case of cDNA sequencing, see chapters “RNA Extraction from FFPE Tissues”, “DNase treatment of RNA” and “Reverse Transcription (RT), then use the obtained cDNA to proceed with PCR. Use 120 ng of cDNA as template for PCR. If necessary, increase up to 200 ng for difficult amplifications. Primers for cDNA amplification should be intron skipping in order to avoid genomic DNA amplification

In the analysis of tumour associated mutations, the selected region of the tissue slide should not contain more than 20–30% of normal cells in order to obtain a reliable result in the sequencing analysis. In particular, consider the contamination from lymphocytes infiltrating the tumour

A very accurate quantification of DNA solution is recommended because the PCR for the sequencing analysis requires proper DNA template amounts. When a very little amount of DNA is expected, quantification with a Nanodrop spectrophotometer is recommended because it allows a reliable quantification using only 1 μl of sample

In order to prevent further degradation, whatever the source of the extracted DNA, multiple DNA freezing and thawing should be avoided. For this reason, after quantification, the concentrated DNA sample should be divided into aliquots suitable for the following PCR amplification. The dilutions can be stored at 4°C for a short time (3–4 weeks). The quantification of the concentrated DNA solution should be repeated after each thawing

It is important to reduce the primers to optimal concentration because an excess could result in primer dimers formation and thus interfere with sequencing giving a higher background in the electropherograms

Lowering the amount of Taq polymerase can reduce the presence of aspecific products Amplifying nanograms of target DNA is troublesome with smaller volumes

A good suggestion is to start with 5–20 ng of DNA template (usually the high DNA degradation caused by formalin does not allow amplifying less than 5 ng). If no PCR products are obtained, try to increase the quantity (do not exceed 500 ng; in case design primers for shorter amplicons)

Freeze-thawing of the PCR products causes their degradation and consequently result in electropherograms with high background. For this reason, it is suggested to store the amplified DNA at 4°C. However, if the PCR products have been frozen repeatedly, good sequencing results may be still obtained by using a higher amount of PCR product (50–100 ng) in the sequencing reaction without changing the amount of primers

Do not confuse polyacrylamide artifacts with aspecific products: the former consist in thin and weak bands of high molecular weight (far more than 1 kbp) and do not interfere with the sequencing reaction

Since the DNA is highly diluted, this step is necessary to allow an accurate spectrophotometric DNA quanti­fication

The Dehydration step can be performed at 60°C in a thermoblock with open tube caps

The probability that the artifacts detected in the first round of PCR appear in a second independent PCR amplification is extremely low

On-line free software, such as “ClustalW” (www.ebi.ac.uk/Tools/clustalw2/index.html) can be used to perform the alignment

References

  1. Gerhardus A, Schleberger H, Schlegelberger B, Gadzicki D (2007) Diagnostic accuracy of methods for the detection of BRCA1 and BRCA2 mutations: a systematic review. Eur J Hum Genet 15(6):619–627 ArticlePubMedCASGoogle Scholar
  2. Spittle C, Ward MR, Nathanson KL, Gimotty PA, Rappaport E, Brose MS, Medina A, Letrero R, Herlyn M, Edwards RH (2007) Application of a BRAF pyrosequencing assay for mutation detection and copy number analysis in malignant melanoma. J Mol Diagn 9(4):464–471 ArticlePubMedCASGoogle Scholar
  3. van Krieken JH, Jung A, Kirchner T, Carneiro F, Seruca R, Bosman FT, Quirke P, Flejou JF, Plato Hansen T, de Hertogh G, Jares P, Langner C, Hoefler G, Ligtenberg M, Tiniakos D, Tejpar S, Bevilacqua G, Ensari A (2008) KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an ­European quality assurance program. Virchows Arch 453(5):417–431 ArticlePubMedGoogle Scholar
  4. Lynch TJ, Bell DW, Sordella R, Gurubhagavatula S, Okimoto RA, Brannigan BW, Harris PL, Haserlat SM, Supko JG, Haluska FG, Louis DN, Christiani DC, Settleman J, Haber DA (2004) Activating mutations in the epidermal growth factor receptor underlying responsiveness of ­non-small-cell lung cancer to gefitinib. N Engl J Med 350(21):2129–2139 ArticlePubMedCASGoogle Scholar
  5. Srinivasan M, Sedmak D, Jewell S (2002) Effect of fixatives and tissue processing on the content and integrity of nucleic acids. Am J Pathol 161(6):1961–1971 ArticlePubMedCASGoogle Scholar
  6. Stanta G, Mucelli SP, Petrera F, Bonin S, Bussolati G (2006) A novel fixative improves opportunities of nucleic acids and proteomic analysis in human archive’s tissues. Diagn Mol Pathol 15(2):115–123 ArticlePubMedCASGoogle Scholar
  7. Quach N, Goodman MF, Shibata D (2004) In vitro mutation artifacts after formalin fixation and error prone translesion synthesis during pcr. BMC Clin Pathol 4(1):1 ArticlePubMedGoogle Scholar

Author information

Authors and Affiliations

  1. Department of Medical, Surgical and Health Sciences, University of Trieste, Cattinara Hospital, Strada di Fiume 447, Trieste, Italy Giorgio Basili, Serena Bonin & Isabella Dotti
  1. Giorgio Basili